Effect of cloretazine on acute myeloid leukaemia blasts in vitro as a single agent and combined with cytarabine and daunorubicin

被引：0
|
作者：
Morris, K. [1 ]
Wren, D. [1 ]
Adams, J. A. [1 ]
Yin, J. A. Liu [1 ]
机构：
[1] Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1120
引用
收藏
页码：412 / 412
页数：1
相关论文
共 50 条
  • [31] A Retrospective Comparison of Hypomethylating Agent in Combination with Venetoclax Versus Liposomal Daunorubicin and Cytarabine in Frontline Treatment of Acute Myeloid Leukemia
    Maher, Keri R.
    Bouligny, Ian M.
    BLOOD, 2021, 138
  • [32] Assessing Efficacy and Safety of Daunorubicin and Cytarabine Liposomal in Patients with Acute Myeloid Leukemia
    Rogers, Elizabeth
    Hibino, Maho
    Hunt, Rebecca Garcia
    Ellis, Leslie Renee
    Bhave, Rupali
    Howard, Dianna S.
    Lyerly, Susan
    Dralle, Sarah
    Manuel, Megan
    Pardee, Timothy S.
    Powell, Bayard L.
    BLOOD, 2019, 134
  • [33] The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
    I Hubeek
    R W Stam
    G J Peters
    R Broekhuizen
    J P P Meijerink
    E R van Wering
    B E S Gibson
    U Creutzig
    C M Zwaan
    J Cloos
    D J Kuik
    R Pieters
    G J L Kaspers
    British Journal of Cancer, 2005, 93 : 1388 - 1394
  • [34] The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
    Hubeek, I
    Stam, RW
    Peters, GJ
    Broekhuizen, R
    Meijerink, JPP
    van Wering, ER
    Gibson, BES
    Creutzig, U
    Zwaan, CM
    Cloos, J
    Kuik, DJ
    Pieters, R
    Kaspers, GJL
    BRITISH JOURNAL OF CANCER, 2005, 93 (12) : 1388 - 1394
  • [35] DAT (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID-LEUKEMIA
    REES, JKH
    HAYHOE, FGJ
    LANCET, 1978, 1 (8078): : 1360 - 1361
  • [36] Leukaemic blasts in a urine specimen in acute myeloid leukaemia with CEBPA mutation
    Li, Ting
    Zhang, Yun
    Wang, Kaifeng
    Zhou, Hui
    Zhang, Junge
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 212 - 212
  • [37] Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin plus Cytarabine with Daunorubicin plus Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia
    Wang, Jing
    Yang, Yong-Gong
    Zhou, Min
    Xu, Jing-Yan
    Zhang, Qi-Guo
    Zhou, Rong-Fu
    Chen, Bing
    Ouyang, Jian
    PLOS ONE, 2013, 8 (04):
  • [38] Venetoclax Combined with Daunorubicin and Cytarabine (2+6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial
    Suo, Xiaohui
    Wang, Dongmei
    Zheng, Fang
    Zhang, Suping
    Zhang, Congcong
    Li, Yinling
    Shi, Rui
    Wu, Yan
    Yang, Sisi
    Zhao, Liyun
    Jiao, Zongjiu
    Liu, Jie
    Zhang, Ling
    Li, Ling
    Zhang, Zhihua
    Lu, Xinxiao
    Yuan, Linyu
    Gao, Sifeng
    Zhang, Jilei
    Zhao, Xingli
    Bai, Guanchen
    Mi, Yingchang
    Liu, Kaiqi
    BLOOD, 2023, 142
  • [39] Results of a randomised comparison of oral etoposide, thioguanine and idarubicin (ETI) with thioguanine, cytarabine and daunorubicin (TAD) in elderly patients with acute myeloid leukaemia
    Ruutu, T
    Almqvist, A
    Hallman, H
    Honkanen, T
    Jarvenpaa, E
    Jarventie, G
    Koistinen, P
    Koivunen, E
    Lahtinen, R
    Lehtinen, M
    Nousiainen, T
    Pelliniemi, TT
    Rajamaki, A
    Remes, K
    Sarkkinen, R
    Sinisalo, M
    Timonen, T
    Volin, L
    Elonen, E
    ORAL CYTOTOXIC TREATMENT IN HAEMATOLOGICAL MALIGNANCIES, 1996, 18 (03): : 53 - 59
  • [40] Venetoclax combined with daunorubicin and cytarabine (2+6) in acute myeloid leukemia: Updated results of a phase II trial
    Suo, Xiaohui
    Fang, Zheng
    Wang, Dongmei
    Zhao, Liyun
    Liu, Jie
    Li, Hong
    Ma, Xiaojun
    Zhang, Congcong
    Zhao, Xuemei
    Shi, Rui
    Wu, Yan
    Jiao, Zongjiu
    Song, Jiaojie
    Zhang, Ling
    Li, Ling
    Zhang, Suping
    Lu, Xinxiao
    Yuan, Linyu
    Gao, Sifeng
    Zhang, Jilei
    Liu, Kaiqi
    Zhao, Xingli
    Bai, Guanchen
    Mi, Yingchang
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (04)
12345